Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, New York
- Most recent report
- 10-Q, filed Nov 4, 2026
- Incorporated
- Delaware
- Filings on record
- 659 filings
- On EDGAR
- CIK 1690585
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 35
News 8 of 89
Prospectuses and Registrations 8 of 50
- S-3ASR Automatic shelf registration Sep 18, 2026
- 424B5 Prospectus supplement for an offering Mar 11, 2026
- 424B5 Prospectus supplement for an offering Mar 9, 2026
- S-8 Registration statement for an employee plan Mar 9, 2026
- S-3 Shelf registration statement Jan 28, 2026
- 424B5 Prospectus supplement for an offering Sep 11, 2025
- 424B5 Prospectus supplement for an offering Sep 8, 2025
- S-8 Registration statement for an employee plan Mar 11, 2025
Proxies 8 of 14
- DEFA14A Extra proxy material Apr 9, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 9, 2026
- DEFA14A Extra proxy material Apr 10, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2025
- DEFA14A Extra proxy material Apr 11, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 11, 2024
- DEFA14A Extra proxy material May 2, 2022
- DEF 14A Proxy statement for a shareholder vote May 2, 2022
Ownership 8 of 406
- 144 Notice of a proposed sale of restricted stock Nov 9, 2026
- SCHEDULE 13G Large holder reported a passive stake Oct 30, 2026
- 4 Insider reported a trade Sep 18, 2026
- 144 Notice of a proposed sale of restricted stock Sep 17, 2026
- 4 Insider reported a trade Sep 3, 2026
- 144 Notice of a proposed sale of restricted stock Sep 1, 2026
- 4 Insider reported a trade Aug 19, 2026
- 4 Insider reported a trade Aug 14, 2026
Other 8 of 65
- ARS Annual report sent to shareholders Apr 9, 2026
- S-3MEF Mar 10, 2026
- EFFECT Notice that a registration became effective Jan 30, 2026
- CORRESP Reply to SEC staff Jan 29, 2026
- UPLOAD Comment letter from SEC staff Jan 29, 2026
- ARS Annual report sent to shareholders Apr 10, 2025
- RW Oct 21, 2024
- EFFECT Notice that a registration became effective Oct 9, 2024
Everything here comes from Dianthus Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.